This information can correlate cell subsets with disease progression and response to treatment as previously seen for HNSCC, where certain CD4+ and CD8+ T-cell phenotypes correlated with longer progression-free survival35,36. The gene discussed is CD8A; the disease is head and neck squamous cell carcinoma.